Karin Allenspach Jorn
Karin Allenspach received her veterinary degree from the University of Zurich. She did an internship in small animal emergency medicine and critical care at Tufts University and a residency in small animal internal medicine at the University of Pennsylvania and is a Diplomate of the European College of Veterinary Internal Medicine. She was awarded a PhD in veterinary immunology from the University of Bern, Switzerland for her work on canine chronic enteropathies. She is currently employed as Professor of Comparative Medicine at the University of Georgia, Athens, GA, and is a PI of the SMART Translational Medicine Lab at UGA, which focuses on the development and culture of adult stem stem-cell-derived organoids from various species. Karin is widely published and has a current H factor of 43. She has been internationally involved in several large-scale efforts to change governmental policies for veterinary medicine, for example by being a member of the ENOVAT group which is providing language for antibiotic use in dogs with diarrhea for all European countries. Furthermore, she has been a Board member of both the European and Comparative Gastroenterology Societies, as well as being president of the European Congress of Veterinary Internal Medicine for 12 years. Her latest efforts have resulted in the founding of a start-up company (3D Health Solutions, Inc.) with the goal of commercializing assays for drug screening based on organoid methods.